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Purpose: 90Y-microsphere radioembolization or selective internal radiation therapy is increasingly
being used as a treatment option for tumors that are not candidates for surgery and external beam
radiation therapy. Recently, volumetric 90Y-dosimetry techniques have been implemented to explore
tumor dose–response on the basis of 3D 90Y-activity distribution from PET imaging. Despite being a
theranostic study, the optimization of quantitative 90Y-PET image reconstruction still uses the mean
activity concentration recovery coefficient (RC) as the objective function, which is more relevant to
diagnostic and detection tasks than is to dosimetry. The aim of this study was to optimize 90Y-PET
image reconstruction by minimizing errors in volumetric dosimetry via the dose volume histogram
(DVH). We propose a joint optimization of the number of equivalent iterations (the product of the
iterations and subsets) and the postreconstruction filtration (FWHM) to improve the accuracy of
voxel-level 90Y dosimetry.
Methods: A modified NEMA IEC phantom was used to emulate clinically relevant 90Y-PET imag-
ing conditions through various combinations of acquisition durations, activity concentrations,
sphere-to-background ratios, and sphere diameters. PET data were acquired in list mode for 300 min
in a single-bed position; we then rebinned the list mode PET data to 60, 45, 30, 15, and 5 min per
bed, with 10 different realizations. Errors in the DVH were calculated as root mean square errors
(RMSE) of the differences in the image-based DVH and the expected DVH. The new optimization
approach was tested in a phantom study, and the results were compared with the more commonly
used objective function of the mean activity concentration RC.
Results: In a wide range of clinically relevant imaging conditions, using 36 equivalent iterations
with a 5.2-mm filtration resulted in decreased systematic errors in volumetric 90Y dosimetry, quanti-
fied as image-based DVH, in 90Y-PET images reconstructed using the ordered subset expectation
maximization (OSEM) iterative reconstruction algorithm with time of flight (TOF) and point spread
function (PSF) modeling. Our proposed objective function of minimizing errors in DVH, which
allows for joint optimization of 90Y-PET iterations and filtration for volumetric quantification of the
90Y dose, was shown to be superior to conventional RC-based optimization approaches for image-
based absorbed dose quantification.
Conclusion: Our proposed objective function of minimizing errors in DVH, which allows for joint
optimization of iterations and filtration to reduce errors in the PET-based volumetric quantification
90Y dose, is relevant to dosimetry in therapy procedures. The proposed optimization method using
DVH as the objective function could be applied to any imaging modality used to assess voxel-level
quantitative information. © 2018 American Association of Physicists in Medicine [https://doi.org/
10.1002/mp.13269]
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1. INTRODUCTION
Selective internal radiation therapy (SIRT) using 90Y-micro-
spheres, also referred to as 90Y-radioembolization, is a loco-
regional liver-directed therapy for nonresectable liver
cancer.1–5 During 90Y-radioembolization, radioactive 90Y-
microspheres (~30 lm in size) are delivered intra-arterially
to liver tumors for permanent implantation. Because of their
embolic size, the microspheres become trapped in the
microvasculature of tumor capillary vessels. The radioactive
beta particle emissions from trapped 90Y-microspheres deli-
ver high radiation doses to proximal tissue (tumors) while
sparing distal tissue (normal liver).
Initially, 90Y-microsphere therapy was used primarily for
palliative care; therefore, 90Y-SIRT treatment planning focused
only on minimizing normal liver toxicity. To date, the package
insert dosimetry model for treatment planning with commer-
cially available 90Y-microsphere devices assumes a uniform
distribution of microspheres in the treatment volume (that
includes tumors and normal liver tissue).6–8 This simplistic
model typically underestimates the radiation dose to the tumor
and overestimates the dose to the normal liver.9 Partition
model dosimetry was proposed as an alternative to overcome
the limitation of uniform activity distribution within the liver
by accounting for the preferential (higher) uptake in tumors
but still assuming uniform uptake within the individual tumor
and normal liver compartments.10 The ideal scenario for parti-
tion model dosimetry is a single tumor and uniform uptake in
both tumor and normal liver regions. However, the accuracy
and validity of partition model dosimetry is tenuous in the
presence of multiple lesions with varied uptake or nonuniform
uptake in the normal liver compartment (as is the typical clini-
cal scenario).9,11 Nonetheless, partition model dosimetry has
been used by a number of investigators to better separate radia-
tion-absorbed dose estimates between the tumor and normal
liver compartments.12–14 It has been reported in numerous clin-
ical practices that patients who received 90Y-SIRT had better
clinical outcomes, including better local control and overall
survival, than did those who received supportive palliative
care.15–17 Furthermore, correlations between tumor dose and
tumor response have also been reported.12,14,15,18 The observed
improvement in survival (albeit in retrospective studies in most
cases) and evolving knowledge on the tumor dose–response
have shifted the treatment planning paradigm from safety to a
more front-line therapy aimed at elucidating tumor response.
While estimation of the mean organ-absorbed doses is suf-
ficient for palliative treatment planning, the dosimetry task for
delivering 90Y-SIRT with a therapeutic intent should aim to
calculate the normal tissue complication probability and tumor
control probability for the individual therapy plan (as is done
routinely in radiation oncology treatment planning). Accurate
determination of these two end points requires volumetric
information on the absorbed dose distribution for the tumor
and normal liver tissue;19–21 therefore, there is an acute need
for accurate quantitative 3D dosimetry of 90Y-SIRT and the
establishment of absorbed dose–response characteristics for
both tumors and organs at risk, such as the liver and lungs.
Volumetric 90Y dosimetry techniques have been imple-
mented on the basis of 3D 90Y-activity distribution from both
90Y-bremsstrahlung SPECT/CT11,22,23 and 90Y-PET/CT24–27
imaging. It has also been shown that the local deposition
method can be used to generate 90Y-absorbed dose maps
(Gy) by scaling the quantitative SPECTor PET images (Bq/mL)
using a single conversion factor (Gy mL/Bq).11,26,28,29 The
3D dose distribution on the SPECT- or PET-based 90Y dose
map can be then interrogated using the dose volume his-
togram (DVH).27,28,30,31 The DVH is a plot of the threshold
dose in the abscissa against the fraction of the volume of
interest (VOI) with the dose greater than or equal to the
threshold dose in the ordinate. The conventional summary
metrics, such as the minimum, maximum, and median doses,
can also be retrieved from the DVH. The ordinate of the
DVH ranges from 0% to 100%, and the slope of the DVH
curve around the median is indicative of the degree of unifor-
mity of the 3D dose distribution in the VOI.
90Y-PET imaging poses unique challenges, primarily due
to the extremely low positron yield of 32 9 106 per 90Y dis-
integration.32 As a comparison, the positron yield in the 18F
decay process is 97 9 102 per disintegration. To compen-
sate for the low signal, 90Y-PET images are typically acquired
for 20–30 min/bed instead of the usual 2–3 min/bed in the
18FDG-PET study. During 90Y-radioembolization, about
3 GBq (80 mCi) of 90Y microspheres are deposited in the
liver. In contrast, for the 18FDG-PET study, about 370 MBq
(10 mCi) of 18FDG is distributed in the whole body. The true
coincidence counts acquired per bed position in 90Y-micro-
sphere PET imaging are therefore up to 100 times lower than
the true coincidence counts acquired by 18FDG-PET imaging.
Consequently, the performance characteristics of recon-
structed 90Y-PET images at such low signal levels, in terms
of the image quality (noise and artifacts) and quantification
(accuracy and precision), are not well understood, unlike
those for 18FDG-PET images.
Image noise and partial volume effect are major degrading
factors that limit the accuracy of voxel-based dosimetry.19
Furthermore, there has been no standardization of the data
acquisition and image reconstruction schemas for 90Y-PET
imaging.33 In routine clinical implementation, the iterative
reconstruction parameters are chosen by balancing quantita-
tive accuracy with image noise and reconstruction time. The
typical approach in iterative reconstruction is to iterate so as
to clearly visualize large tumors and then apply filtration to
smooth the final image. Recent studies of OSEM reconstruc-
tion parameter optimization for quantitative 90Y-PET imaging
used the mean activity concentration recovery coefficient
(RC) as the objective function.34–38 While an increase in the
number of equivalent iterations (defined as the product of
iterations and subsets) improves the image resolution and
accuracy of the mean activity concentration, it also increases
the image noise.39 As a further complication, the degree of
convergence with iterative reconstruction approaches depends
on a large number of parameters, including the sphere size
and the sphere-to-background ratio (SBR). After convergence
is achieved, an increase in the number of equivalent iterations
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only results in higher image noise. The usual practice of
using postreconstruction filtration (e.g., Gaussian) to reduce
image noise leads to an underestimation of the mean activity
concentration to a severe degree, depending on the magnitude
of the filter (i.e., the full width at half maximum [FWHM]).
Therefore, we posit that the RC is not well suited as the
objective function for the optimization of reconstruction
related to volumetric dosimetry quantification.
Our long-term goal is to perform a systematic investigation
of the bias and variability in 90Y-PET-based absorbed dose
quantification; this effort has been separated into two parts. In
this study, the scope of our work was to develop an appropriate
metric for assessing the performance of 90Y-PET for absorbed
dose quantification. Specifically, the objective was not to eval-
uate the performance of 90Y-PET dose quantification but to
introduce an appropriate metric to assess its performance. We
propose a joint optimization of the 90Y-PET image reconstruc-
tion protocol (i.e., the number of equivalent iterations and the
postreconstruction filtration FWHM) to improve the accuracy
of voxel-level 3D volumetric 90Y dosimetry from count-starved
90Y-PET images by directly interrogating the errors in the
resultant DVH. The performance of 90Y-PET image recon-
struction was also evaluated using the traditional RC of the
mean sphere dose. We report on the optimization of the 90Y-
PET image reconstruction protocol in a phantom using a modi-
fied NEMA IEC phantom study under a wide range of clini-
cally relevant imaging conditions: sphere sizes, activity
concentrations, SBRs, and acquisition durations.
In a subsequent study, we will use the metric proposed
here to investigate the numerous variables related to introduc-
ing errors in the performance of 90Y-PET-based dose quan-
tification (e.g., image count, image count rate, sphere size,
sphere dose, SBR, and background signal).
2. MATERIALS AND METHODS
2.A. Data acquisition and phantom description
A modified NEMA IEC phantom (Biodex, Shirley, NY)
was used to emulate clinically relevant 90Y PET imaging con-
ditions through various combinations of acquisition dura-
tions, activity concentrations, sphere-to-background ratios
(SBR), and sphere diameters. The modified IEC phantom
contained two sphere sets of 37, 17, and 13 mm diameters
each. These spheres were filled with 90Y activity concentra-
tion of 4.8 MBq/mL (130 lCi/mL) and 1.6 MBq/mL
(43 lCi/mL); the background chamber was filled with
0.4 MBq/mL (10 lCi/mL) to give SBR of 13 and 4 for the
two sphere sets.
The PET data for the IEC phantom were acquired in list
mode using a GE D690 PET/CT scanner (General Electric,
Milwaukee, WI) for 300 min in a single-bed position. The
90Y radionuclide was programmed into the scanner with a
half-life of 64.1 h and a branching ratio of 32 9 106. The
spheres were positioned at the center of the PET axial field of
view (FOV). We replayed the list mode PET data to 60, 45,
30, 15, and 5 min per bed to evaluate the potential variation
in optimum reconstruction parameters under a range of signal
conditions. Furthermore, by taking advantage of the list mode
acquisition, each reconstruction was performed using 10 dif-
ferent realizations. The DVH and RC values reported were
based on the average of the 10 different realizations to dimin-
ish the impact of the statistical (random) noise. The reported
behavior would then mainly be affected by uncertainties
stemming from the reconstruction algorithm and the system
spatial resolution. In addition to the initial day 0 acquisition
described, we reacquired the PET data in list mode on day 3
when the sphere ACs had decayed to 2.3 and 0.8 MBq/mL to
assess the potential variation in optimal reconstruction
parameters due to the count rate during acquisition.
The PET/CT images were reconstructed using the 3D
ordered subset expectation maximization (3D OSEM) algo-
rithm with point spread function (PSF) and time of flight
(TOF) modeling (GE VPFXS). The number of iterations var-
ied from 1 to 12, while the number of subsets was fixed at 12;
this resulted in equivalent iterations that ranged from 12 to
144. Postreconstruction Gaussian filters were applied in the
transaxial plane; the FWHM of the filters were 0, 2.6, 5.2,
7.8, and 10.4 mm. The voxel size was 2.6 9 2.6 9 3.3 mm3.
All reconstructed 90Y-PET images (the activity concentration
map in Bq/mL) were multiplied by a scaling factor of
4.78 9 105 Gy.mL/Bq to convert them to a 90Y dose map
(Gy) via the local deposition method (LDM).26 The corre-
sponding absorbed doses of the sphere sets were 230 and
77 Gy on day 0, and 110 and 37 Gy on day 3.
2.B. DVH optimization
The 3D 90Y dose distribution in the hot spheres was inves-
tigated using DVH.27 The sphere DVHs were calculated from
the sphere VOI in the PET images. These sphere VOI were
defined on the basis of the segmentation of their correspond-
ing CT images, as illustrated in Fig. 1.
Two objective metrics were used to evaluate the quantita-
tive 90Y PET image reconstruction: (a) minimization of the
errors in the sphere DVH and (b) maximization of the RC for
the mean sphere dose. Errors in the DVH were calculated as
root mean square errors (RMSE) of the differences in the
image-based sphere DVH and the reference DVH, that is,
RMSE ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃP80
20
DxDx;refð Þ2
60
r
: Here, Dx is the PET image-based
DVH at x% volume coverage, whereas Dx,ref is the expected
DVH at x% volume coverage on the basis of the phantom
setup. The PET-based DVHs in this study were based on 3D
90Y dose distributions that had been determined using the
LDM on PET images that converted 3D activity concentra-
tion distributions into 3D absorbed dose distributions. The
corresponding reference 3D absorbed dose and DVH distri-
butions were calculated using the dose-point kernel (DPK)
convolution method.26,40,41 Using isotropic 2.21-mm voxels
and the corresponding voxel S-values from Lanconelli
et al.,41 we applied DPK convolution to the known 90Y activ-
ity concentration in the spheres and background to obtain the
reference 3D absorbed dose. The dose kernels from
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Lanconelli et al. account for the beta spectra—they simulate
several monoenergetic betas and then weigh the spectra
accordingly. The reference DVH were not calculated from
PET images; thus, they were degraded by neither PET image
noise nor resolution. The limiting resolution in our reference
DVH was the voxel size, which was set to an isotropic
2.21 mm.
Dose-point kernel is a voxel dosimetry technique that uses
voxel S-values41,42 for 90Y and can account for the exchange
of energy deposition at the sphere boundary due to electron
transport. The b particles emitted during 90Y decay have a
maximum energy of 2.28 MeV, a mean tissue penetration of
2.5 mm, and a maximum range of 1.1 cm. Therefore, some
of the b particles from 90Y disintegrations near the sphere
boundary may exit the sphere and deposit their energy in the
background medium, leading to a lower absorbed dose at the
peripheral voxels of the spheres. Consequently, the reference
DVHs are not rectangular. We compared the reference DVH
against the DVH realized by 90Y-PET images to assess scan-
ner performance. Therefore, no additional modeling of the
PET system resolution or other degradation factors was
applied to the reference DVH.
The RMSEs were calculated from D80 to D20 to avoid
high errors near the maximum (D0) and minimum (D100)
doses due to high image noise in the count-starved 90Y PET
study.27 The RMSE for each sphere DVH was calculated as
an average of 10 different image noise realizations; the stan-
dard errors were reported. RMSE were calculated for all
image reconstruction parameter combinations (the number of
equivalent iterations and the filtration FWHM).
To determine the sensitivity of RMSE to the selection of
dose threshold ranges, we also investigated RMSE trends as a
function of dose threshold ranges: D0–D100, D10–D90, D20–
D80, D30–D70, D50–D80, and D60–D90.
2.C. RC convergence method
As a comparison, the reconstruction parameters were also
optimized using the conventional objective function of the
sphere RC, calculated as RC = Dmean/Dtrue, where, Dmean is
the mean dose in the sphere calculated from CT-contoured
VOI, and Dtrue is the known absorbed dose in the sphere cal-
culated using the LDM with the known 90Y activity concen-
tration. Here again, the sphere RC were calculated as an
average of 10 different image noise realizations. The conver-
gence properties of the sphere RC were evaluated under the
various aforementioned imaging conditions. For optimization
using RC convergence, no postreconstruction filtration was
applied to PET images because the application of any
smoothing filter will increase the partial volume effect and
decrease the RC;33,43,44 hence, in this study, RC convergence
was only determined by calculating the sphere RC as a func-
tion of the number of equivalent iterations.
3. RESULTS
3.A. DVH optimization
Images of the modified IEC phantom (day 0, 15-min
acquisition), reconstructed for different numbers of equivalent
iterations (12–48) but with a fixed filtration of 5.2-mm
FWHM, are shown in Fig. 2(a); note the increase in image
noise with the higher number of equivalent iterations. The
same data (day 0, 15-min acquisition) reconstructed for a
fixed number of 36 equivalent iterations but different filtra-
tions (2.6–10.4-mm FWHM) are shown in Fig. 2(b); note the
decrease in image noise with the higher amount of filtration.
The corresponding DVH of the 17-mm sphere (day 0, 15-min
acquisition, SBR of 13, dose of 230 Gy) are shown in
Figs. 2(c) and 2(d) as a function of the number of equivalent
iterations and filtration FWHM, respectively. The increase in
image noise with higher equivalent iterations and lower filtra-
tions widens the distribution in the DVH profile, especially at
the higher voxel doses (i.e., bottom right region).
The solid black curves in Figs. 2(c) and 2(d) indicate the
reference DVH, calculated using the DPK convolution
method. Although the activity concentrations in the spheres
are uniform, some of the b particles from 90Y
FIG. 1. Illustration of CT-based spherical volumes of interest used to segment the 37- and 17 mm hot spheres. [Color figure can be viewed at wileyonlinelibrary.c
om]
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disintegrations near the sphere boundary exit the sphere and
deposit their energy in the background medium, leading to a
lower absorbed dose at the peripheral voxels of the spheres;
hence, the reference DVHs are not rectangular.
The RMSE of the image-based DVH for the 17-mm
sphere (day 0, 15 min acquisition, 13 SBR, 230 Gy dose), as
a function of equivalent iterations [corresponding to
Fig. 2(c)] and filtration FWHM [corresponding to Fig. 2(d)],
are shown in Fig. 3. The standard errors of selected DVH
RMSE are also shown as the error bars. The small error bars
indicate that the RMSE curves in Fig. 3 are minimally influ-
enced by stochastic noise. The RMSEs of DVH were among
the lowest around 36 equivalent iterations; a further increase
in the number of equivalent iterations resulted in higher
noise, as evidenced by the increased spread of DVH
[Fig. 2(c)] and increased RMSE (Fig. 2), which was more
apparent in images with less filtration. Similarly, the RMSE
of the DVH was the lowest at a filtration of 5.2-mm FWHM;
heavier filtration shifted the DVH toward lower doses and
resulted in a higher underestimation of DVH [Fig. 2(d)].
A similar RMSE behavior was observed at different dose
levels for the 17-mm sphere at a dose of 37 Gy [Fig. 3(b)]
and for different sphere sizes and doses [Figs. 2(c) and 2(d)].
The DVH RMSE in a larger sphere image (37 mm in diame-
ter) was the lowest at an equivalent iteration of 24, while the
RMSE in a smaller sphere image (13 mm in diameter) was
the lowest at 48 equivalent iterations. However, image recon-
struction of all spheres (diameter of 37–13 mm) using 36
equivalent iterations resulted in a change of absolute errors in
the DVH of <1% at all volume coverages.
As the sphere image noise (or dose nonuniformity)
increased due to lower dose or shorter duration, 7.8-mm fil-
tration resulted in lower RMSE of DVH than did 5.2-mm
filtration. Changes in the mean dose (nominal 77 Gy) for the
17-mm sphere DVH, calculated from sphere images (day 0,
15 min acquisition) with 5.2 and 7.8-mm filtration, were
<3% at volume coverage of 20–80%, on average.
While the use of image filtration suppresses image noise
and hence reduces noise-dependent errors in DVH, it also
increases the errors in DVH due to increased partial volume
effect. Heavier filtration with FWHM of 7.8 and 10.4 mm
could be used on a larger sphere (37-mm sphere), where par-
tial volume effect is less severe, to further reduce the RMSE
of DVH estimate; however, filtration beyond 7.8 mm FWHM
did not significantly improve the DVH (<2% absolute change
at all volume coverage). In contrast, the use of filtration with
FHWM wider than 5.2 mm increased the RMSE of DVH in
smaller spheres, for example, the in 17-mm sphere [Figs. 2(d)
and 3]. We found that images reconstructed using equivalent
iterations of 24–48 and filtrations of 5.2–7.8 mm FWHM
yielded RMSE of sphere DVH that were consistently among
the lowest in various tested imaging conditions.
The RMSE calculated using the entire dose threshold
range, from D0 to D100, increased monotonically with a
higher number of equivalent iterations (Fig. 4). This increase
in noise may be related to the fact that (a) image noise
increases with a higher number of equivalent iterations and
(b) high noise levels were observed at both the low and high
DVH coverages (see Fig. 2). Consequently, when the extrema
of DVH were excluded in the calculation of the RMSE, such
as D20–D80 and D30–D70, we observed an initial decrease in
the RSME before the monotonic increase with equivalent iter-
ations, as shown in Fig. 4. RMSE trends, when the very low
and the very high dose coverages were excluded, were simi-
lar, as a function of equivalent iterations — that is, RMSEs
were the lowest at 36 equivalent iterations with 5.2-mm
FIG. 2. PET images of the modified IEC phantom reconstructed using the number of equivalent iterations (the product of the iteration and subsets) of 12, 24, 36,
and 48 (a) and postreconstruction filtration FWHM of 2.6, 5.2, 7.8, and 10.4 mm (b). (c, d) The corresponding DVH of the 17-mm sphere (nominal dose
230 Gy) calculated from (a) and (b), respectively. The solid black curves indicate the reference DVH, which was calculated using the dose-point kernel convolu-
tion method. [Color figure can be viewed at wileyonlinelibrary.com]
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filtration (Fig. 4). We chose a dose threshold range of D20–
D80 as a conservative approach to avoid noise-related errors
near the extremes, which cause high errors (Fig. 2).
3.B. RC convergence method
The converged RC value was seen to depend on the scan
duration, with lower RC observed for shorter durations
[Fig. 5(a)]. The spread in converged RC values, as a function
of the scan duration, increased with the decrease in sphere
sizes; RC values of 70–75% (spread of 5%) were observed
for the 37-mm sphere with 15–60 min/bed that increased to
35–50% (spread of 15%) for the 13-mm sphere [Fig. 5(a)].
The converged value of RC decreased with smaller sphere
sizes, ranging from 75% for 34 mm spheres to 55% for 13-
mm spheres [Fig. 5(b)]. The converged value, however, was
largely insensitive to the SBR and sphere dose [Fig. 5(b)].
The convergence rates were found to be higher at the
higher dose level. Figure 5(c) shows faster RC convergence
for both the 34- and 17-mm spheres at 230 Gy compared to
the rates observed when the activity in the spheres had
decreased to 64 Gy. The rate of convergence for RC was lar-
gely insensitive to sphere sizes, SBR, and acquisition dura-
tion, as shown in Figs. 5(a) and 5(b). Overall, spheres with
various imaging conditions achieved RC convergence after
36 equivalent iterations.
4. DISCUSSION
The goal of 90Y PET is not tumor detection but rather
estimation of the radiation dose delivered to the tumor (at
the voxel level). Therefore, the accuracy of the PET image
in terms of the quantitative pixel value in Bq/mL is of the
highest relevance. As the number of equivalent iterations
increases, the sphere activity concentration (or dose) begins
to converge; however, the image noise increases as well.
Transaxial filtration can be used to reduce the image noise,
but it blurs the image, which results in changes in dose dis-
tribution (smeared), with the degree of severity depending
on the FWHM of the filtration and the sphere sizes. Using
the DVH RMSE as an objective function allows for
joint optimization of both equivalent iterations and filtra-
tion simultaneously. Thirty-six equivalent iterations with
5.2-mm filtration result in the smallest RMSE across vari-
ous imaging conditions.
Optimization using the mean RC dose does not take into
account the alteration in dose distribution due to changes in
FIG. 3. Root mean square errors (RMSEs) in the sphere dose volume histogram (DVH) estimates as a function number of equivalent iterations (the product of
the iteration and subsets) and filtration full width at half maximum (FWHM) for a (a) 17-mm sphere with a dose of 230 Gy and acquisition duration of 15 min,
(b) 17-mm sphere with a dose of 37 Gy and acquisition duration of 15 min, (c) 37-mm sphere with a dose of 110 Gy and acquisition duration of 15 min, and (d)
13-mm sphere with a dose of 230 Gy and acquisition duration of 15 min. The RMSE was calculated as an average of RMSE in five noise realizations. The stan-
dard errors of RMSE (black vertical error bar) are shown. Using 36 equivalent iterations with 5.2-mm filtration, RMSEs of sphere DVH estimates were consis-
tently among the lowest. [Color figure can be viewed at wileyonlinelibrary.com]
FIG. 4. Root mean square errors (RMSEs) of the 17-mm sphere (110 Gy)
dose volume histogram (DVH) estimate for various dose threshold ranges.
Using the entire range, D0–D100, resulted in an optimization systematic error
in which a low number of equivalent iterations (the product of the iteration
and subsets) is preferred to avoid high errors due to noise-degraded images.
[Color figure can be viewed at wileyonlinelibrary.com]
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image noise, such as increased noise from a higher number
of equivalent iterations and reduced noise from a higher fil-
tration FWHM. The converged RC value depended on the
scan duration, with a lower RC observed for shorter scan
durations, especially for the small (<20 mm) spheres. This
may be attributed to the ultra-low signal regimen for 90Y
PET compared to that for clinical 18-FDG scans. 90Y PET
image noise degraded both quantification precision and
accuracy. Since spatial filtration reduces the mean RC dose,
reconstruction parameter optimization using the mean dose
RC as the objective function would suggest minimum filtra-
tion. However, as shown in Figs. 2 and 3, sphere images
with no or low filtration resulted in higher errors in DVH.
While it appears that the mean RC is too simplistic a
metric for the 3D absorbed dose quantification, it is,
nonetheless, a direct measure of the quantitative image
accuracy (recall that the mean RC is the ratio of the esti-
mated value to the true value). While the standard deviation
of the mean dose RC can be used to minimize the
increased noise from higher number equivalent iterations, it
cannot be used to optimize the FWHM of the filtration.
Wider FWHM filtration will monotonically result in a
lower standard deviation.
In general, the objective function of reconstruction param-
eter optimization needs to match the imaging tasks. For
dosimetry, where the end points are accurate 3D absorbed
dose quantifications, the noise distribution plays an important
role, as shown in this study. In fact, the asymmetric magnifi-
cation of noise with lower counts or higher iterations may
also perturb the mean value. It is precisely in such situations
that the use of DVH RMSE as an objective function is
advantageous. As demonstrated here, it allows for joint
optimization of both equivalent iterations and filtration
simultaneously.
This study was limited to phantom studies using a modi-
fied NEMA IEC phantom. Spheres with uniform doses were
not true representations of heterogeneous 90Y-microsphere
distribution in the tumor. The effects of voxel size and z-axis
filtration were not evaluated in this work. Both of these
parameters can be optimized to further reduce errors in DVH,
but PET spatial resolution is still a limiting factor for calculat-
ing accurate DVH [Fig. 2(c) and 2(d)].
We only evaluated DVH-based optimization in the GE
VPFXS reconstruction algorithm (OSEM with TOF and
PSF). The method, however, can be used to optimize recon-
struction parameters in other reconstruction algorithms, for
example, the Bayesian penalized-likelihood reconstruction
algorithm, where the DVH RMSE can be minimized by
adjusting the b and c parameters instead of the number of
equivalent iterations and filtration FWHM.
In our previous study,27 we found that low-count PET
images reconstructed using OSEM caused both random and
systematic errors. In a future study, we will use the 3D 90Y-
dose map reconstructed using the optimization schema from
this study to evaluate both random and systematic errors of
the DVH in count-starved 90Y-PET studies. This study will
help establish the accuracy and precision of quantifying the
3D 90Y dose from PET images.
5. CONCLUSION
Conventional PET image reconstruction optimization aims
to increase lesion detection or reduce errors in SUV measure-
ment; both of which are more relevant to diagnostic tasks
than to theranostic procedures such as post-therapy 90Y PET
imaging. Our proposed objective function of minimizing
errors in DVH, which allows for joint optimization of
90Y-PET iterations and filtration to reduce errors in the
PET-based volumetric quantification 90Y dose, is more rele-
vant to dosimetry in therapy procedures. We recommend
using 36 equivalent iterations with 5.2-mm filtration for 90Y-
PET images reconstructed using VPFXS (GE OSEM with
TOF and PSF). The proposed optimization method using
DVH as the objection function could be applied more gener-
ally to any imaging modality assessing voxel-level quantita-
tive information.
FIG. 5. Sphere mean dose recovery coefficient (RC) as a function of the
number of equivalent iterations (the product of the iteration and subsets) for
(a) three sphere sizes with three acquisition durations, (b) three sphere sizes
with two sphere-to-background ratios (SBRs), and (c) three sphere sizes with
two dose levels and an SBR of 13. The convergence rates of the sphere RC
were insensitive to sphere sizes, durations, SBRs, and dose levels; after sub-
set 9 iterations of 36, all sphere RCs in various imaging conditions reached
convergence. [Color figure can be viewed at wileyonlinelibrary.com]
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